Skip to content

Australian Chlamydia Control Effectiveness PIlot: a trial to determine whether annual chlamydia testing in general practice can lead to a reduction in chlamydia prevalence.

A randomised controlled trial to determine whether an intervention of annual chlamydia testing in general practice for sexually active men and women aged 16 to 29 years can lead to a reduction in chlamydia prevalence

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000297022
Acronym
ACCEPt
Enrollment
52
Registered
2010-04-13
Start date
2010-08-16
Completion date
2012-12-15
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The overall design of ACCEPT for the purposes of the Department of Health and Ageing (DoHA) contract has been finalised and approved by ethics committees. The trial uses a cluster randomised controlled trial (RCT) design. Cluster randomisation is required because chlamydia is an infectious disease; randomising a group of people in the same geographic area (postcode) will allow the intervention to be delivered to people within the same social/sexual networks. The intervention aims to maximise the rate of regular chlamydia testing in people in the target age group who attend primary care services. The intervention will be randomised at the postcode level and all GP clinics and Aboriginal Community Controlled Health Services (ACCHS) in each postcode (estimated at 2-3 clinics on average) will be invited to participate. Overall, about 80% of postcodes will be selected from rural/regional areas based on the Rural, Remote and Metropolitan Areas classification (RRMA 3-7) so that the intervention can be applied to whole communities of people more likely to be in the same social/sexual network. Further, because young people often attend multiple clinics, randomising postcodes in rural areas and recruiting all clinics in the postcode, will allow the intervention to be applied to whole communities and facilitate data collection. The fundamental premise of this trial is that increased levels of testing can be achieved by providing a supportive intervention and that once levels of testing are increased high enough (more than 30%), the prevalence of chlamydia will fall.

Interventions

General practitioners will be provided with a multifaceted intervention to support increased chlamydia testing in general practice. The intervention includes computer alerts, incentive payments, educational package, register to recall patients for follow up tests and quarterly feedback on chlamydia testing performance. The trial will be of up to 4 years duration.

Sponsors

UNiversity of Melbourne
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
Yes

Inclusion criteria

The intervention will be allocated at the postcode area and all general practice clinics within the postcode will be invited to participated. All clinics will be eligible for participation. General practitioners (GPs) will be asked to screen sexually active men and women aged 16 to 29 years for chlamydia.

Exclusion criteria

None

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 12, 2026